Prophylactic and therapeutic potential of vitamin D in asthma during the COVID-19 pandemic: the new hope?

Abstract

Over the last two decades, the emergence of lethal virulent strains of coronavirus (CoV), including the severe acute respiratory syndrome CoV 2 (SARS-CoV-2), which is responsible for the coronavirus disease 2019 (COVID-19) pandemic, has become a matter of great attention to the scientific community. Despite the implementation of preventive measures throughout the world, the spread of this disease and associated co-morbidities and mortality continue in all countries, continents, and populations of all ages. COVID-19 is highly contagious. Clinical manifestations are diverse and range from asymptomatic, mild to severe, life-threatening complications in the elderly and patients with underlying conditions such as cardiovascular disease, diabetes, obesity, and asthma. In addition, viral infections can trigger asthma attacks. To date, there is no specific treatment schema to combat COVID-19 disease. Current patient care revolves around disease severity and supportive treatment of symptoms from home-rest in mild disease to anti-viral therapy, oxygen support, anti-inflammatories, and anti-coagulants in severe COVID-19. Regarding prevention, the World Health Organization recommends vaccination, social distancing, quarantine, the wearing of surgical masks, and handwashing. In many countries, vaccination is optional, and given that parents are often reluctant to vaccinate themselves and their children for fear of side effects, identifying ways to enhance or support the immune system to prevent infection or improve recovery in vulnerable populations is worth investigating. Furthermore, research has focused on the pharmacological management of COVID-19 symptoms and much less has been published on nutrition therapy. Therefore, the scope of this review is to summarize the latest evidence on the use of vitamin D to support the metabolism and the immune system of asthma patients during the COVID-19 pandemic. A brief overview of asthma and COVID-19 pathophysiology, COVID-19 treatment guidelines for asthma patients, and the role of vitamin D in lung health, including the optimal blood level required to enhance immunity, will be suggested.

Keywords

COVID-19 / SARS-CoV-2 / vitamin D / nutrition / asthma / respiratory disease

References

[1] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. ; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382: 1708-20.

[2] Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, et al. A new threat from an old enemy: Re-emergence of coronavirus (Review). Int J Mol Med. 2020; 45: 1631-43.

[3] WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. WHO; c2024 [cited 2023 Jun 23]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-March-2020

[4] Coronavirus disease (COVID-19) pandemic [Internet]. WHO; c2024 [cited 2023 Jun 28]. Available from: https://www.who.int/europe/emergencies/situations/covid-19

[5] Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L, et al. Economic Burden of COVID-19: A Systematic Review. Clinicoecon Outcomes Res. 2022; 14: 293-307.

[6] Keogh-Brown MR, Jensen HT, Edmunds WJ, Smith RD. The impact of Covid-19, associated behaviours and policies on the UK economy: A computable general equilibrium model. SSM Popul Health. 2020; 12: 100651.

[7] Nurchis MC, Pascucci D, Sapienza M, Villani L, D’Ambrosio F, Castrini F, et al. Impact of the Burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and Productivity Loss. Int J Environ Res Public Health. 2020; 17: 4233.

[8] Viscusi WK. Pricing the global health risks of the COVID-19 pandemic. J Risk Uncertain. 2020; 61: 101-28.

[9] Advice for the public: Coronavirus disease (COVID-19) [Internet]. WHO; c2024 [cited 2023 Jun 26]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public

[10] Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020; 75: 1699-709.

[11] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054-62. Erratum in: Lancet. 2020; 395:1038.

[12] Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020; 584: 430-6.

[13] Maleki Dana P, Sadoughi F, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B, et al. An Insight into the Sex Differences in COVID-19 Patients: What are the Possible Causes? Prehosp Disaster Med. 2020; 35: 438-41.

[14] Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020; 13: 1833-9.

[15] Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ Open. 2020; 10: e040129.

[16] Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020; 55: 2000688.

[17] Pijls BG, Jolani S, Atherley A, Dijkstra JIR, Franssen GHL, Hendriks S, et al. Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients. F1000Res. 2022; 11: 5.

[18] Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003; 8: S9-14.

[19] de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013; 87: 7790-2.

[20] Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109: 1088-95.

[21] Riley S, Wang H, Eales O, Haw D, Walters CE, Ainslie KEC, et al.; The COVID-19 Genomics UK (COG-UK) Consortium; Ashby D, Donnelly CA, Cooke G, Barclay W, Ward H, Darzi A, et al. REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant. medRxiv 2021.06.17.21259103 [Preprint]. 2021 [cited 2023 Sep 15]. Available from: https://www.medrxiv.org/content/10.1101/2021.06.17.21259103v1

[22] Antimalarial use in COVID-19 patients requires close monitoring. Reactions Weekly. 2020; 1802: 1.

[23] COVID-19 Treatment and Preventive Medication [Internet]. [cited 2023 Jun 27]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html

[24] Buchholz K. The Countries Where Covid-19 Vaccination Is Mandatory [Internet]. [cited 2023 Jul 11]. Available from: https://www.statista.com/chart/25326/obligatory-vaccination-against-covid-19/

[25] Khan YH, Rasheed M, Mallhi TH, Salman M, Alzarea AI, Alanazi AS, et al. Barriers and facilitators of childhood COVID-19 vaccination among parents: A systematic review. Front Pediatr. 2022; 10: 950406.

[26] Nawas GT, Zeidan RS, Edwards CA, El-Desoky RH. Barriers to COVID-19 Vaccines and Strategies to Improve Acceptability and Uptake. J Pharm Pract. 2023; 36: 900-4.

[27] Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. ; COVE Study Group. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021; 384: 403-16.

[28] Petrie JG, King JP, McClure DL, Rolfes MA, Meece JK, Pattinson D, et al. Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. Influenza Other Respir Viruses. 2023; 17: e13104.

[29] Chakraborty C, Bhattacharya M, Sharma AR, Mallik B. Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein. Int J Biol Macromol. 2022; 219: 980-97.

[30] 2022 GINA Report, Global Strategy for Asthma Management and Prevention [Internet]. Global Initiative for Asthma - GINA; c2024 [cited 2024 Feb 9]. Available from: https://ginasthma.org/gina-reports/

[31] Morris MJ, Pearson DJ. Asthma [Internet]. WebMD LLC.; 1994-2024 [cited 2024 Feb 10]. Available from: https://emedicine.medscape.com/article/296301-overview#showall

[32] Asthma [Internet]. WHO; c2024 [cited 2023 Jun 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma

[33] Asher MI, Rutter CE, Bissell K, Chiang CY, El Sony A, Ellwood E, et al. ; Global Asthma Network Phase I Study Group. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. Lancet. 2021; 398: 1569-80.

[34] Song P, Adeloye D, Salim H, Dos Santos JP, Campbell H, Sheikh A, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. J Glob Health. 2022; 12: 04052.

[35] Almqvist C, Worm M, Leynaert B ; working group of GA2LEN WP 2.5 Gender. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy. 2008; 63: 47-57.

[36] Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: is prevention possible? Lancet. 2015; 386: 1075-85.

[37] Kantor DB, Stenquist N, McDonald MC, Schultz BJ, Hauptman M, Smallwood CD, et al. Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children. J Allergy Clin Immunol. 2016; 138: 1467-71.e9.

[38] Dawood FS, Chaves SS, Pérez A, Reingold A, Meek J, Farley MM, et al. ; Emerging Infections Program Network. Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. J Infect Dis. 2014; 209: 686-94.

[39] Guo Y, Zou Y. The detection and evaluation of pathogens and PCR methods for diagnosis of respiratory tract infection in children. Tianjin Med J. 2017; 12: 1005-8.

[40] Tsakiris A, Iordanidou M, Paraskakis E, Tsalkidis A, Rigas A, Zimeras S, et al. The presence of asthma, the use of inhaled steroids, and parental education level affect school performance in children. Biomed Res Int. 2013; 2013: 762805.

[41] Reiter J, Ramagopal M, Gileles-Hillel A, Forno E. Sleep disorders in children with asthma. Pediatr Pulmonol. 2022; 57: 1851-9.

[42] Gans MD, Gavrilova T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2020; 36: 118-27.

[43] Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, et al. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front Immunol. 2021; 12: 693938.

[44] Aghamirza Moghim Aliabadi H, Eivazzadeh-Keihan R, Beig Parikhani A, Fattahi Mehraban S, Maleki A, Fereshteh S, et al. COVID-19: A systematic review and update on prevention, diagnosis, and treatment. MedComm (2020). 2022; 3: e115.

[45] James KM, Peebles RS Jr, Hartert TV. Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol. 2012; 130: 343-51.

[46] Martono, Fatmawati F, Mulyanti S. Risk Factors Associated with the Severity of COVID-19. Malays J Med Sci. 2023; 30: 84-92.

[47] Sunjaya AP, Allida SM, Di Tanna GL, Jenkins C. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis. J Asthma. 2022; 59: 866-79.

[48] Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and COVID-19 risk: a systematic review and meta-analysis. Eur Respir J. 2022; 59: 2101209.

[49] Davies GA, Alsallakh MA, Sivakumaran S, Vasileiou E, Lyons RA, Robertson C, et al. ; EAVE II Collaborators. Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax. 2021; 76: 867-73.

[50] Karcher H, Schoenberger M, Rayban T, Kelly C, Heaney A, Mackay A. Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients. Allergy Asthma Proc. 2023; 44: 422-8.

[51] Roland D, Harwood R, Bishop N, Hargreaves D, Patel S, Sinha I. Children’s emergency presentations during the COVID-19 pandemic. Lancet Child Adolesc Health. 2020; 4: e32-3.

[52] Hanon S, Brusselle G, Deschampheleire M, Louis R, Michils A, Peché R, et al. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J. 2020; 56: 2002857.

[53] Papadopoulos NG, Mathioudakis AG, Custovic A, Deschildre A, Phipatanakul W, Wong G, et al. ; PeARL collaborators, on behalf of the PeARL Think Tank. Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort. Allergy. 2021; 76: 1765-75.

[54] Lombardi C, Gani F, Berti A, Comberiati P, Peroni D, Cottini M. Asthma and COVID-19: a dangerous liaison? Asthma Res Pract. 2021; 7: 9.

[55] Papadopoulos NG, Custovic A, Deschildre A, Mathioudakis AG, Phipatanakul W, Wong G, et al. ; Pediatric Asthma in Real Life Collaborators. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020; 8: 2592-9.e3.

[56] Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, et al. COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids. Am J Respir Crit Care Med. 2020; 202: 83-90. Erratum in: Am J Respir Crit Care Med. 2020; 202:1744-6.

[57] Zimmermann P, Curtis N. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features. Pediatr Infect Dis J. 2020; 39: 469-77.

[58] Kumar N, Sharma S, Barua S, Tripathi BN, Rouse BT. Virological and Immunological Outcomes of Coinfections. Clin Microbiol Rev. 2018; 31: 10.1128/cmr.00111-17.

[59] Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020; 146: 203-6.e3.

[60] Bunyavanich S, Do A, Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA. 2020; 323: 2427-9.

[61] Jha A, Dunning J, Tunstall T, Thwaites RS, Hoang LT; MOSAIC Investigators; Kon OM, Zambon MC, Hansel TT, Openshaw PJ. Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza. Eur Respir J. 2019; 54: 1900949.

[62] Groneberg DA, Eynott PR, Lim S, Oates T, Wu R, Carlstedt I, et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology. 2002; 40: 367-73.

[63] Bonser LR, Erle DJ. Airway Mucus and Asthma: The Role of MUC5AC and MUC5B. J Clin Med. 2017; 6: 112.

[64] Rosenberg HF, Dyer KD, Domachowske JB. Respiratory viruses and eosinophils: exploring the connections. Antiviral Res. 2009; 83: 1-9.

[65] Ferastraoaru D, Hudes G, Jerschow E, Jariwala S, Karagic M, de Vos G, et al. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. J Allergy Clin Immunol Pract. 2021; 9: 1152-62.e3.

[66] Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014; 43: 343-73. Erratum in: Eur Respir J. 2014; 43:1216. Erratum in: Eur Respir J. 2018;52:1352020. Erratum in: Eur Respir J. 2022;59:1362020.

[67] Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, Brown JP, et al. ; OpenSAFELY Collaborative. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020; 8: 1106-20.

[68] Caminati M, Vultaggio A, Matucci A, Senna G, Almerigogna F, Bagnasco D, et al. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021; 176: 106261.

[69] Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75: 1730-41.

[70] GINA: interim guidance about COVID-19 & asthma [Internet]. Global Initiative for Asthma - GINA; c2024 [cited 2024 Feb 9]. Available from: https://ginasthma.org/covid-19/

[71] Abrams EM, Szefler S. Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down? Lancet Respir Med. 2021; 9: 820-2.

[72] Final NIH Coronavirus Disease (COVID-19) Treatment Guidelines (February 29, 2024) [Internet]. [cited 2024 Feb 11]. Available from: https://www.covid19treatmentguidelines.nih.gov/

[73] Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, et al. ; GS-US-540-5774 Investigators. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020; 324: 1048-57.

[74] Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al. ; GS-US-540-9012 (PINETREE) Investigators. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. N Engl J Med. 2022; 386: 305-15.

[75] Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. ; EPIC-HR Investigators. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med. 2022; 386: 1397-408.

[76] Schwartz KL, Wang J, Tadrous M, Langford BJ, Daneman N, Leung V, et al. Population-based evaluation of the effectiveness of nirmatrelvir-ritonavir for reducing hospital admissions and mortality from COVID-19. CMAJ. 2023; 195: E220-6.

[77] Pfizer Reports Additional Data on PAXLOVID^TM Supporting Upcoming New Drug Application Submission to U.S. FDA [Internet]. Pfizer Inc. ; c2024 [cited 2024 Feb 15]. Available from: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-reports-additional-data-paxlovidtm-supporting

[78] Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, et al. Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge. N Engl J Med. 2022; 387: 790-8.

[79] FDA Approves First Treatment for COVID-19 [Internet]. [cited 2024 Feb 15]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19

[80] WHO Expands Recommendation for Veklury^® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline [Internet]. Drugs.com; c2000- 2024 [cited 2024 Feb 15]. Available from: https://www.drugs.com/clinical_trials/expands-recommendation-veklury-remdesivir-patients-severe-latest-update-covid-19-guideline-20395.html

[81] Fact sheet for healthcare providers: emergency use authorization for Paxlovid^TM [Internet]. [cited 2024 Feb 15]. Available from: https://www.fda.gov/media/155050/download

[82] Therapeutic Management of Nonhospitalized Adults With COVID-19 [Internet]. [cited 2024 Feb 15]. Available from: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/nonhospitalized-adults--therapeutic-management/

[83] WHO Solidarity Trial Consortium. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet. 2022; 399: 1941-53. Erratum in: Lancet. 2022;400:1512. Erratum in: Lancet. 2024;403:146.

[84] Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. ; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020; 383: 1813-26.

[85] Garibaldi BT, Wang K, Robinson ML, Betz J, Caleb Alexander G, Andersen KM, et al. Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness Study. Clin Infect Dis. 2022; 75: e516-24.

[86] Amstutz A, Speich B, Mentré F, Rueegg CS, Belhadi D, Assoumou L, et al. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med. 2023; 11: 453-64. Erratum in: Lancet Respir Med. 2023; 11:e77.

[87] Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Jiang H, et al. Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice. Clin Infect Dis. 2023; 77: 1626-34.

[88] Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Lee E, et al. Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants. Open Forum Infect Dis. 2023; 10: ofad482.

[89] Crothers K, DeFaccio R, Tate J, Alba PR, Goetz MB, Jones B, et al. ; Veterans Aging Cohort Study Clinical COVID-19 Working Group. Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support. Eur Respir J. 2022; 60: 2102532.

[90] Bradley MC, Perez-Vilar S, Chillarige Y, Dong D, Martinez AI, Weckstein AR, et al. Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021. JAMA. 2022; 327: 2015-8.

[91] Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, et al. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021; 897: 173947.

[92] RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021; 384: 693-704.

[93] Zeng Y, Zeng W, Yang B, Liu Z. Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis. Med Clin (Engl Ed). 2022; 159: 575-83.

[94] Li J, Liao X, Zhou Y, Wang L, Yang H, Zhang W, et al. Comparison of Associations Between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis. Shock. 2021; 56: 215-28.

[95] WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020; 324: 1330-41.

[96] King H. Let Food Be Thy Medicine. In: Hippocrates Now: The ‘Father of Medicine’ in the Internet Age. London: Bloomsbury Academic; 2020. pp. 111-32.

[97] Noncommunicable diseases: Childhood overweight and obesity [Internet]. WHO; c2024 [cited 2023 Jul 19]. Available from: https://www.who.int/news-room/questions-and-answers/item/noncommunicable-diseases-childhood-overweight-and-obesity

[98] Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. ; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006; 368: 1673-9.

[99] Zhang YB, Pan XF, Chen J, Cao A, Xia L, Zhang Y, et al. Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies. J Epidemiol Community Health. 2021; 75: 92-9.

[100] Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol. 2020; 75: 235-51.

[101] Mastrangelo A, Barbas C. Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics. In: Sussulini A, editor. Metabolomics: From Fundamentals to Clinical Applications. Cham: Springer International Publishing; 2017. pp. 235-63.

[102] Suarez-Lledo V, Alvarez-Galvez J. Prevalence of Health Misinformation on Social Media: Systematic Review. J Med Internet Res. 2021; 23: e17187.

[103] Borges do Nascimento IJ, Pizarro AB, Almeida JM, Azzopardi-Muscat N, Gonçalves MA, Björklund M, et al. Infodemics and health misinformation: a systematic review of reviews. Bull World Health Organ. 2022; 100: 544-61.

[104] Nutrition advice for adults during the COVID-19 outbreak [Internet]. WHO; c2024 [cited 2023 Jun 28]. Available from: https://www.emro.who.int/nutrition/covid-19/nutrition-advice-for-adults-during-the-covid-19-outbreak.html

[105] Al-Fartusie FS, Kader SI, Mohammed SJ, Farhan MN, Mahmood FM, Algaber AA. A comparative study of serum Zn, Cu, Mg, Mn, Cr, and Fe levels and their association with the vulnerability of Iraqi COVID-19 patients. J Trace Elem Med Biol. 2023; 79: 127242.

[106] Hurst EA, Mellanby RJ, Handel I, Griffith DM, Rossi AG, Walsh TS, et al. ; ISARIC4C Investigators. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study. BMJ Open. 2021; 11: e055435.

[107] Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup P. Vitamin D deficiency, impaired lung function and total and respiratory mortality in a cohort of older men: cross-sectional and prospective findings from The British Regional Heart Study. BMJ Open. 2021; 11: e051560.

[108] Radujkovic A, Hippchen T, Tiwari-Heckler S, Dreher S, Boxberger M, Merle U. Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients. 2020; 12: 2757.

[109] Yılmaz K, Şen V. Is vitamin D deficiency a risk factor for COVID-19 in children? Pediatr Pulmonol. 2020; 55: 3595-601.

[110] Zhu Y, Jing D, Liang H, Li D, Chang Q, Shen M, et al. Vitamin D status and asthma, lung function, and hospitalization among British adults. Front Nutr. 2022; 9: 954768.

[111] Wang Q, Ying Q, Zhu W, Chen J. Vitamin D and asthma occurrence in children: A systematic review and meta-analysis. J Pediatr Nurs. 2022; 62: e60-8.

[112] Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. ; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 1911-30. Erratum in: J Clin Endocrinol Metab. 2011; 96:3908.

[113] Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017; 18: 153-65.

[114] Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016; 103: 1033-44.

[115] Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020; 74: 1498-513.

[116] Manios Y, Moschonis G, Lambrinou CP, Tsoutsoulopoulou K, Binou P, Karachaliou A, et al. A systematic review of vitamin D status in southern European countries. Eur J Nutr. 2018; 57: 2001-36.

[117] Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011; 58: 186-92.

[118] Lee JH, Gadi R, Spertus JA, Tang F, O’Keefe JH. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol. 2011; 107: 1636-8.

[119] Md Isa Z, Amsah N, Ahmad N. The Impact of Vitamin D Deficiency and Insufficiency on the Outcome of Type 2 Diabetes Mellitus Patients: A Systematic Review. Nutrients. 2023; 15: 2310.

[120] Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr. 2011; 94: 225-33.

[121] Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72: 690-3. Erratum in: Am J Clin Nutr. 2003;77:1342.

[122] Weinstein SJ, Purdue MP, Smith-Warner SA, Mondul AM, Black A, Ahn J, et al. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer. 2015; 136: E654-64.

[123] Lokesh KS, Chaya SK, Jayaraj BS, Praveena AS, Krishna M, Madhivanan P, et al. Vitamin D deficiency is associated with chronic obstructive pulmonary disease and exacerbation of COPD. Clin Respir J. 2021; 15: 389-99.

[124] Liu J, Dong YQ, Yin J, Yao J, Shen J, Sheng GJ, et al. Meta-analysis of vitamin D and lung function in patients with asthma. Respir Res. 2019; 20: 161.

[125] Bener A, Ehlayel MS, Bener HZ, Hamid Q. The impact of Vitamin D deficiency on asthma, allergic rhinitis and wheezing in children: An emerging public health problem. J Family Community Med. 2014; 21: 154-61.

[126] Jat KR. Vitamin D deficiency and lower respiratory tract infections in children: a systematic review and meta-analysis of observational studies. Trop Doct. 2017; 47: 77-84.

[127] Monlezun DJ, Bittner EA, Christopher KB, Camargo CA, Quraishi SA. Vitamin D status and acute respiratory infection: cross sectional results from the United States National Health and Nutrition Examination Survey, 2001-2006. Nutrients. 2015; 7: 1933-44.

[128] Chiodini I, Gatti D, Soranna D, Merlotti D, Mingiano C, Fassio A, et al. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Front Public Health. 2021; 9: 736665.

[129] Xyda SE, Kotsa K, Doumas A, Papanastasiou E, Garyfallos AA, Samoutis G. Could the Majority of the Greek and Cypriot Population Be Vitamin D Deficient? Nutrients. 2022; 14: 3778.

[130] Alpdemir M, Alpdemir MF. Vitamin D deficiency status in Turkey: A meta-analysis. Int J Med Lab. 2019; 2: 118-31.

[131] Ramnemark A, Norberg M, Pettersson-Kymmer U, Eliasson M. Adequate vitamin D levels in a Swedish population living above latitude 63°N: The 2009 Northern Sweden MONICA study. Int J Circumpolar Health. 2015; 74: 27963.

[132] Summerhays E, Eliasson M, Lundqvist R, Söderberg S, Zeller T, Oskarsson V. Time trends of vitamin D concentrations in northern Sweden between 1986 and 2014: a population-based cross-sectional study. Eur J Nutr. 2020; 59: 3037-44.

[133] Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014; 39: 322-50.

[134] Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, et al. The Effect of Vitamin D on Falls: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2011; 96: 2997-3006.

[135] Lopez AG, Kerlan V, Desailloud R. Non-classical effects of vitamin D: Non-bone effects of vitamin D. Ann Endocrinol (Paris). 2021; 82: 43-51.

[136] Jani R, Mhaskar K, Tsiampalis T, Kassaw NA, González MÁM, Panagiotakos DB. Circulating 25-hydroxy-vitamin D and the risk of cardiovascular diseases. Systematic review and meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. 2021; 31: 3282-304.

[137] Turkeli A, Ayaz O, Uncu A, Ozhan B, Bas VN, Tufan AK, et al. Effects of vitamin D levels on asthma control and severity in pre-school children. Eur Rev Med Pharmacol Sci. 2016; 20: 26-36.

[138] Papamichael MM, Itsiopoulos C, Lambert K, Katsardis C, Tsoukalas D, Erbas B. Sufficient vitamin D status positively modified ventilatory function in asthmatic children following a Mediterranean diet enriched with fatty fish intervention study. Nutr Res. 2020; 82: 99-109.

[139] Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010; 65: 215-20.

[140] Golan-Tripto I, Loewenthal N, Tal A, Dizitzer Y, Baumfeld Y, Goldbart A. Vitamin D deficiency in children with acute bronchiolitis: a prospective cross-sectional case-control study. BMC Pediatr. 2021; 21: 211.

[141] Talebi F, Rasooli Nejad M, Yaseri M, Hadadi A. Association of Vitamin D Status with the Severity and Mortality of Community-Acquired Pneumonia in Iran during 2016-2017: A Prospective Cohort Study. Rep Biochem Mol Biol. 2019; 8: 85-90.

[142] Gupta D, Vashi PG, Trukova K, Lis CG, Lammersfeld CA. Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature. Exp Ther Med. 2011; 2: 181-93.

[143] Berridge MJ. Vitamin D deficiency and diabetes. Biochem J. 2017; 474: 1321-32.

[144] Bozzetto S, Carraro S, Giordano G, Boner A, Baraldi E. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy. 2012; 67: 10-7.

[145] Liu N, Sun J, Wang X, Zhang T, Zhao M, Li H. Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. Int J Infect Dis. 2021; 104: 58-64.

[146] Alipio MM. Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (Covid-2019). [Preprint]. 2020 [cited 2023 Sep 15]. Available from: https://www.grassrootshealth.net/wp-content/uploads/2020/04/Alipio-Vit-D-COVID-Severity-Preprint-04-22-2020.pdf

[147] Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, et al. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One. 2020; 15: e0239799.

[148] Argano C, Mallaci Bocchio R, Natoli G, Scibetta S, Lo Monaco M, Corrao S. Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis. Pharmaceuticals (Basel). 2023; 16: 130.

[149] Hosseini B, El Abd A, Ducharme FM. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients. 2022; 14: 2134.

[150] Varikasuvu SR, Thangappazham B, Vykunta A, Duggina P, Manne M, Raj H, et al. COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther. 2022; 20: 907-13.

[151] Pal R, Banerjee M, Bhadada SK, Shetty AJ, Singh B, Vyas A. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis. J Endocrinol Invest. 2022; 45: 53-68.

[152] Zurita-Cruz J, Fonseca-Tenorio J, Villasís-Keever M, López-Alarcón M, Parra-Ortega I, López-Martínez B, et al. Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial. Front Pediatr. 2022; 10: 943529.

[153] Xiao L, Xing C, Yang Z, Xu S, Wang M, Du H, et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. Br J Nutr. 2015; 114: 1026-34.

[154] Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021; 9: 276-92.

[155] Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019; 23: 1-44.

[156] Asyary A, Veruswati M. Sunlight exposure increased Covid-19 recovery rates: A study in the central pandemic area of Indonesia. Sci Total Environ. 2020; 729: 139016.

[157] Whittemore PB. COVID-19 fatalities, latitude, sunlight, and vitamin D. Am J Infect Control. 2020; 48: 1042-4.

[158] Shah K, Varna VP, Pandya A, Saxena D. Low vitamin D levels and prognosis in a COVID-19 pediatric population: a systematic review. QJM. 2021; 114: 447-53.

[159] Esfandiar N, Alaei F, Fallah S, Babaie D, Sedghi N. Vitamin D deficiency and its impact on asthma severity in asthmatic children. Ital J Pediatr. 2016; 42: 108.

[160] Bener A, Ehlayel MS, Tulic MK, Hamid Q. Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol. 2012; 157: 168-75.

[161] Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis. 2013; 57: 392-7.

[162] Aziz DA, Abbas A, Viquar W, Munawar Hussain A. Association of vitamin D levels and asthma exacerbations in children and adolescents: Experience from a tertiary care center. Monaldi Arch Chest Dis. 2023; 93: 2230.

[163] Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. ; Childhood Asthma Management Program Research Group. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010; 126: 52-8.e5.

[164] Brehm JM, Acosta-Pérez E, Klei L, Roeder K, Barmada M, Boutaoui N, et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am J Respir Crit Care Med. 2012; 186: 140-6.

[165] Chinellato I, Piazza M, Sandri M, Peroni D, Piacentini G, Boner AL. Vitamin D serum levels and markers of asthma control in Italian children. J Pediatr. 2011; 158: 437-41.

[166] Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010; 125: 995-1000.

[167] Kaaviyaa AT, Krishna V, Arunprasath TS, Ramanan PV. Vitamin D Deficiency as a Factor Influencing Asthma Control in Children. Indian Pediatr. 2018; 55: 969-71.

[168] Sharif A, Haddad Kashani H, Sharif MR. Association of 25-hydroxy vitamin D with asthma and its severity in children: a case-control study. Clin Mol Allergy. 2020; 18: 7.

[169] Raju A, Luthra G, Shahbaz M, Almatooq H, Foucambert P, Esbrand FD, et al. Role of Vitamin D Deficiency in Increased Susceptibility to Respiratory Infections Among Children: A Systematic Review. Cureus. 2022; 14: e29205.

[170] Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009; 169: 384-90.

[171] Braegger C, Campoy C, Colomb V, Decsi T, Domellof M, Fewtrell M, et al. ; ESPGHAN Committee on Nutrition. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr. 2013; 56: 692-701.

[172] Jat KR, Khairwa A. Vitamin D and asthma in children: A systematic review and meta-analysis of observational studies. Lung India. 2017; 34: 355-63.

[173] Cassim R, Russell MA, Lodge CJ, Lowe AJ, Koplin JJ, Dharmage SC. The role of circulating 25 hydroxyvitamin D in asthma: a systematic review. Allergy. 2015; 70: 339-54.

[174] Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006; 116: 146-55.

[175] Kumar J, Kumar P, Goyal JP, Thakur C, Choudhary P, Meena J, et al. Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials. ERJ Open Res. 2022; 8: 00662-2021.

[176] Wang M, Liu M, Wang C, Xiao Y, An T, Zou M, et al. Association between vitamin D status and asthma control: A meta-analysis of randomized trials. Respir Med. 2019; 150: 85-94.

[177] Hao M, Xu R, Luo N, Liu M, Xie J, Zhang W. The Effect of Vitamin D Supplementation in Children With Asthma: A Meta-Analysis. Front Pediatr. 2022; 10: 840617.

[178] Kerley CP, Elnazir B, Faul J, Cormican L. Vitamin D as an adjunctive therapy in asthma. Part 1: A review of potential mechanisms. Pulm Pharmacol Ther. 2015; 32: 60-74.

[179] Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, et al. International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor α, farnesoid X receptor β, liver X receptor α, liver X receptor β, and vitamin D receptor. Pharmacol Rev. 2006; 58: 742-59.

[180] Canadian Nutrient File (CNF) - Search by food [Internet]. [cited 2023 Jul 19]. Available from: https://food-nutrition.canada.ca/cnf-fce/newSearch

[181] Eggenhuizen PJ, Ng BH, Ooi JD. Treg Enhancing Therapies to Treat Autoimmune Diseases. Int J Mol Sci. 2020; 21: 7015.

[182] Gupta A, Dimeloe S, Richards DF, Chambers ES, Black C, Urry Z, et al. Defective IL-10 expression and in vitro steroid-induced IL-17A in paediatric severe therapy-resistant asthma. Thorax. 2014; 69: 508-15.

[183] Dancer RC, Parekh D, Lax S, D’Souza V, Zheng S, Bassford CR, et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax. 2015; 70: 617-24.

[184] Bergeron C, Tulic MK, Hamid Q. Airway remodelling in asthma: from benchside to clinical practice. Can Respir J. 2010; 17: e85-93.

[185] James AL, Elliot JG, Jones RL, Carroll ML, Mauad T, Bai TR, et al. Airway smooth muscle hypertrophy and hyperplasia in asthma. Am J Respir Crit Care Med. 2012; 185: 1058-64.

[186] Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med. 2007; 176: 858-64.

[187] O’Reilly R, Ullmann N, Irving S, Bossley CJ, Sonnappa S, Zhu J, et al. Increased airway smooth muscle in preschool wheezers who have asthma at school age. J Allergy Clin Immunol. 2013; 131: 1024-32.e16.

[188] Salameh L, Mahmood W, Hamoudi R, Almazrouei K, Lochanan M, Seyhoglu S, et al. The Role of Vitamin D Supplementation on Airway Remodeling in Asthma: A Systematic Review. Nutrients. 2023; 15: 2477.

[189] Song Y, Hong J, Liu D, Lin Q, Lai G. 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Scand J Immunol. 2013; 77: 109-16.

[190] Jin A, Tang X, Zhai W, Li Y, Sun Q, Liu L, et al. TSLP-induced collagen type-I synthesis through STAT3 and PRMT1 is sensitive to calcitriol in human lung fibroblasts. Biochim Biophys Acta Mol Cell Res. 2021; 1868: 119083.

[191] O’Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev. 2008; 223: 114-31.

[192] Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med. 2008; 8: 437-45.

[193] Elieh Ali Komi D, Bjermer L. Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights. Clin Rev Allergy Immunol. 2019; 56: 234-47.

[194] Raeiszadeh Jahromi S, Mahesh PA, Jayaraj BS, Madhunapantula SR, Holla AD, Vishweswaraiah S, et al. Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case-control study. J Asthma. 2014; 51: 1004-13.

[195] Zonoobi E, Saeedfar K, Pourdowlat G, Masjedi MR, Behmanesh M. The Study of IL-10 and IL-17A Genes Expression in Patients with Different Stages of Asthma: a Case-Control Study . Tanaffos. 2018; 17: 146-54.

[196] Marshall CL, Hasani K, Mookherjee N. Immunobiology of Steroid-Unresponsive Severe Asthma. Front Allergy. 2021; 2: 718267.

[197] Jirapongsananuruk O, Melamed I, Leung DY. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D₃ and corticosteroids on TH1, but not TH2, responses . J Allergy Clin Immunol. 2000; 106: 981-5.

[198] Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂ vitamin D₃: genomic and non-genomic mechanisms . Best Pract Res Clin Endocrinol Metab. 2011; 25: 543-59.

[199] Qayyum S, Mohammad T, Slominski RM, Hassan MI, Tuckey RC, Raman C, et al. Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes. Am J Physiol Endocrinol Metab. 2021; 321: E246-51.

[200] Zu S, Deng YQ, Zhou C, Li J, Li L, Chen Q, et al. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res. 2020; 30: 1043-5.

[201] Lembo D, Cagno V, Civra A, Poli G. Oxysterols: An emerging class of broad spectrum antiviral effectors. Mol Aspects Med. 2016; 49: 23-30.

[202] Endo-Umeda K, Yasuda K, Sugita K, Honda A, Ohta M, Ishikawa M, et al. 7-Dehydrocholesterol metabolites produced by sterol 27-hydroxylase (CYP27A1) modulate liver X receptor activity. J Steroid Biochem Mol Biol. 2014; 140: 7-16.

[203] Marcello A, Civra A, Milan Bonotto R, Nascimento Alves L, Rajasekharan S, Giacobone C, et al. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients. Redox Biol. 2020; 36: 101682.

[204] Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323: 1239-42.

[205] Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. 2017; 125: 21-38.

[206] Sodhi CP, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton WB, Wang S, et al. Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg⁹ bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration . Am J Physiol Lung Cell Mol Physiol. 2018; 314: L17-31.

[207] Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426: 450-4.

[208] Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005; 436: 112-6.

[209] Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111: 2605-10.

[210] Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020; 41: 1801-3.

[211] Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep. 2017; 16: 7432-8.

[212] Sánchez-Zuno GA, González-Estevez G, Matuz-Flores MG, Macedo-Ojeda G, Hernández-Bello J, Mora-Mora JC, et al. Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation. J Clin Med. 2021; 10: 2378.

[213] Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013; 34: 33-83.

[214] Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021; 292: 198235.

[215] Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, et al. Effect of a Single High Dose of Vitamin D₃ on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial . JAMA. 2021; 325: 1053-60.

[216] Nogues X, Ovejero D, Pineda-Moncusí M, Bouillon R, Arenas D, Pascual J, et al. Calcifediol Treatment and COVID-19-Related Outcomes. J Clin Endocrinol Metab. 2021; 106: e4017-27.

[217] Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One. 2013; 8: e65835.

[218] Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N, et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J. 2022; 98: 87-90.

[219] Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, et al. Effect of high-dose vitamin D₃ on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial . JAMA. 2014; 312: 1520-30. Erratum in: JAMA. 2014; 312:1932.

[220] Amrein K, Parekh D, Westphal S, Preiser JC, Berghold A, Riedl R, et al. ; VITDALIZE Collaboration Group. Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study). BMJ Open. 2019; 9: e031083.

[221] di Filippo L, Formenti AM, Doga M, Frara S, Rovere-Querini P, Bosi E, et al. Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients. Endocrine. 2021; 71: 9-13.

[222] Di Filippo L, Formenti AM, Rovere-Querini P, Carlucci M, Conte C, Ciceri F, et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine. 2020; 68: 475-8.

[223] Martha JW, Wibowo A, Pranata R. Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis. Diabetes Metab Syndr. 2021; 15: 337-42.

[224] Vieth R. Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol. Eur J Clin Nutr. 2020; 74: 1493-7.

[225] Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M, et al. Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? Rev Endocr Metab Disord. 2021; 22: 1201-18.

[226] Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017; 356: i6583.

[227] Tecilazich F, Formenti AM, Giustina A. Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects. Rev Endocr Metab Disord. 2021; 22: 715-27.

[228] Thompson B, Waterhouse M, English DR, McLeod DS, Armstrong BK, Baxter C, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023; 381: e075230.

[229] Zhang Y, Tan H, Tang J, Li J, Chong W, Hai Y, et al. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis. Diabetes Care. 2020; 43: 1650-8.

[230] Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010; 5: e11088.

[231] Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020; 12: 2097.

[232] Czarnik T, Czarnik A, Gawda R, Gawor M, Piwoda M, Marszalski M, et al. Vitamin D kinetics in the acute phase of critical illness: A prospective observational study. J Crit Care. 2018; 43: 294-9.

[233] Amrein K, Papinutti A, Mathew E, Vila G, Parekh D. Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa. Endocr Connect. 2018; 7: R304-15.

[234] Kaur M, Soni KD, Trikha A. Does Vitamin D Improve All-cause Mortality in Critically Ill Adults? An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials. Indian J Crit Care Med. 2022; 26: 853-62.

[235] Jenkinson C, Taylor AE, Hassan-Smith ZK, Adams JS, Stewart PM, Hewison M, et al. High throughput LC-MS/MS method for the simultaneous analysis of multiple vitamin D analytes in serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2016; 1014: 56-63.

[236] Religi A, Backes C, Chatelan A, Bulliard JL, Vuilleumier L, Moccozet L, et al. Estimation of exposure durations for vitamin D production and sunburn risk in Switzerland. J Expo Sci Environ Epidemiol. 2019; 29: 742-52. Erratum in: J Expo Sci Environ Epidemiol. 2019; 29:862.

[237] Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Washington, DC: The National Academies Press; 2011.